Variant report
Variant | nsv965454 |
---|---|
Chromosome Location | chr4:62468858-62469690 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17239087 | chr4:62468873-62468874 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs377705785 | chr4:62468904-62468905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs113027803 | chr4:62468933-62468934 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537745288 | chr4:62468950-62468951 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6820887 | chr4:62469099-62469100 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs191175063 | chr4:62469130-62469131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572535594 | chr4:62469136-62469137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184055275 | chr4:62469148-62469149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527643606 | chr4:62469191-62469192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540578142 | chr4:62469227-62469228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555476539 | chr4:62469312-62469313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574113597 | chr4:62469335-62469336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544908724 | chr4:62469357-62469358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12642140 | chr4:62469361-62469362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34997041 | chr4:62469446-62469447 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs151175768 | chr4:62469447-62469448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576283997 | chr4:62469450-62469451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533537308 | chr4:62469524-62469525 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561772737 | chr4:62469582-62469583 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs545276091 | chr4:62469587-62469588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs377377436 | chr4:62469618-62469619 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78338465 | chr4:62469638-62469639 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs527386014 | chr4:62469651-62469652 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs80151236 | chr4:62469664-62469665 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 20369283 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Cancer | 20164919 | CNVD |
Lung cancer | 20668451 | CNVD |
Intellectual disability | 21811512 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 22522925 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:62460400-62473400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
2 | chr4:62461200-62478000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr4:62461600-62473600 | Weak transcription | Fetal Stomach | stomach |
4 | chr4:62465600-62469400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr4:62468000-62469000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr4:62468200-62469000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr4:62468200-62469000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr4:62468200-62469200 | Enhancers | Fetal Lung | lung |
9 | chr4:62468400-62476800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr4:62469200-62473400 | Weak transcription | Fetal Lung | lung |
11 | chr4:62469400-62470000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr4:62469600-62472800 | Enhancers | Primary monocytes fromperipheralblood | blood |